Medicamen Biotec

Part of MojoOne Strategy

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE646B01010
NSEID: MEDICAMEQ
BSEID: 531146

INR

499.60

6.6 (1.34%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 16.83 k

Click here to access the older version

{
  "main_header": {
    "sid": 770569,
    "name": "Medicamen Biotec",
    "stock_name": "Medicamen Biotec",
    "full_name": "Medicamen Biotech Ltd",
    "name_url": "stocks-analysis/medicamen-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "499.60",
    "chg": 6.6,
    "chgp": "1.34%",
    "dir": 1,
    "prev_price": "493.00",
    "mcapval": "635.22 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531146,
    "symbol": "MEDICAMEQ",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE646B01010",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:06 AM",
    "bse_nse_vol": "16.83 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medicamen-biotec-770569-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "HT",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medicamen-biotec-770569-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Medicamen Biotech Shows Mixed Technical Trends Amid Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotechs-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-increase-3-1656282",
        "imagepath": "",
        "date": "2025-04-01 08:02:34",
        "description": "Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 479.30, showing a notable increase from the previous close of 453.40. Over the past year, Medicamen has demonstrated a strong performance with a return of 25.11%, significantly outpacing the Sensex, which recorded a return of 5.11% in the same period.\n\nIn terms of technical indicators, the weekly MACD and Bollinger Bands suggest a bearish sentiment, while the monthly MACD indicates a mildly bullish trend. The daily moving averages lean towards a mildly bearish outlook, reflecting mixed signals in the short term. The KST also shows a bearish trend on a weekly basis, contrasting with a mildly bullish monthly perspective.\n\nDespite recent fluctuations, Medicamen's long-term performance remains impressive, particularly..."
      },
      {
        "title": "Medicamen Biotech Faces Technical Trend Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotechs-technical-trend-changes-from-mildly-bearish-to-bearish-amid-stock-price-decline-1598529",
        "imagepath": "",
        "date": "2025-03-26 08:03:29",
        "description": "Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 451.00, down from a previous close of 477.35, with a 52-week high of 630.00 and a low of 377.00. Today's trading saw a high of 483.65 and a low of 451.00, indicating some volatility.\n\nThe technical summary reveals a bearish sentiment in several indicators. The MACD shows a bearish trend on a weekly basis, while the monthly perspective is mildly bullish. Bollinger Bands and moving averages also reflect bearish conditions, suggesting a cautious outlook. The KST indicates a bearish trend weekly, with a mildly bullish stance monthly. Notably, the RSI shows no signals on both weekly and monthly charts, indicating a lack of momentum.\n\nIn terms of performance, Medicamen Biotech's stock return over the past week stands at..."
      },
      {
        "title": "Medicamen Biotech's Technical Trends Indicate Mixed Outlook Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotechs-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-increase-1572962",
        "imagepath": "",
        "date": "2025-03-24 08:01:49",
        "description": "Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 485.30, showing a notable increase from the previous close of 474.65. Over the past year, Medicamen Biotech has demonstrated a return of 19.31%, significantly outperforming the Sensex, which recorded a return of 5.87% in the same period.\n\nThe technical summary indicates a mixed outlook, with the MACD showing bearish signals on a weekly basis while being mildly bullish on a monthly scale. The Bollinger Bands reflect a mildly bearish trend weekly, and moving averages also suggest a mildly bearish stance. Notably, the KST presents a similar divergence, indicating bearish momentum weekly but a mildly bullish trend monthly.\n\nIn terms of stock performance, Medicamen Biotech has experienced fluctuations, with a 52-week h..."
      },
      {
        "title": "Medicamen Biotech Faces Technical Trend Shift Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotechs-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-stock-decline-3-1425407",
        "imagepath": "",
        "date": "2025-03-18 08:02:47",
        "description": "Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 414.40, down from a previous close of 430.10, with a 52-week high of 630.00 and a low of 377.00. \n\nThe technical summary indicates a bearish sentiment in various indicators, including the MACD and Bollinger Bands on both weekly and monthly charts. The moving averages also reflect a bearish trend, while the KST shows a mildly bullish stance on a monthly basis. The Relative Strength Index (RSI) currently shows no signal, suggesting a lack of momentum in either direction.\n\nIn terms of performance, Medicamen Biotech's returns have varied significantly over different time frames. Over the past week, the stock has seen a decline of 5.84%, while the Sensex has remained relatively stable with a return of 0.07%. On a year-..."
      },
      {
        "title": "Medicamen Biotech Faces Stock Volatility Amidst Mixed Long-Term Performance Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-reports-3-98-annual-growth-despite-recent-stock-decline-1412226",
        "imagepath": "",
        "date": "2025-03-17 18:00:33",
        "description": "Medicamen Biotech Ltd, a microcap player in the Pharmaceuticals & Drugs industry, has experienced notable fluctuations in its stock performance. With a market capitalization of Rs 547.00 crore, the company currently holds a price-to-earnings (P/E) ratio of 62.65, significantly higher than the industry average of 35.59.\n\nOver the past year, Medicamen Biotech has shown a performance increase of 3.98%, outperforming the Sensex, which rose by 2.10%. However, recent trends indicate a decline, with the stock down 3.65% today, contrasting with the Sensex's gain of 0.46%. The stock has also faced challenges over the past week and month, with declines of 5.84% and 7.04%, respectively.\n\nLonger-term performance metrics reveal a more complex picture. Year-to-date, Medicamen Biotech is down 18.63%, while over three years, it has decreased by 38.06%. In contrast, the stock has shown significant growth over the past five ..."
      },
      {
        "title": "Medicamen Biotech Faces Mixed Technical Trends Amid Market Volatility and Declining Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotechs-technical-trend-shifts-from-sideways-to-mildly-bearish-amid-stock-decline-1378862",
        "imagepath": "",
        "date": "2025-03-12 08:02:12",
        "description": "Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 413.10, down from a previous close of 440.10, with a notable 52-week high of 630.00 and a low of 356.75. Today's trading saw a high of 458.95 and a low of 410.25, indicating some volatility in its performance.\n\nThe technical summary reveals a mixed outlook, with the MACD showing bearish signals on a weekly basis while maintaining a mildly bullish stance monthly. The Bollinger Bands and KST also reflect bearish trends on a weekly basis, suggesting caution in the short term. Meanwhile, moving averages indicate a mildly bullish trend daily, which contrasts with the overall bearish sentiment observed in other indicators.\n\nIn terms of returns, Medicamen Biotech has faced challenges compared to the Sensex. Over the past..."
      },
      {
        "title": "Medicamen Biotech Experiences Technical Trend Adjustments Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotechs-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-decline-1288588",
        "imagepath": "",
        "date": "2025-03-11 08:03:24",
        "description": "Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs sector, has recently undergone a technical trend adjustment. The company's current stock price stands at 440.10, reflecting a notable decline from the previous close of 481.15. Over the past year, Medicamen has faced challenges, with a stock return of -6.76%, contrasting with a marginally positive return of -0.01% for the Sensex during the same period.\n\nThe technical summary indicates mixed signals across various indicators. The MACD shows a bearish trend on a weekly basis while being mildly bullish monthly. The Bollinger Bands and KST also reflect bearish tendencies on a weekly scale, with the moving averages indicating a mildly bullish stance daily. Notably, the Relative Strength Index (RSI) shows no significant signals for both weekly and monthly evaluations.\n\nIn terms of performance, Medicamen's stock has experienced a significant drop ..."
      },
      {
        "title": "Medicamen Biotech Faces Technical Trend Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotechs-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-stock-price-increase-1201442",
        "imagepath": "",
        "date": "2025-03-05 08:02:19",
        "description": "Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 478.95, slightly above its previous close of 477.50. Over the past year, Medicamen has experienced a 52-week high of 630.00 and a low of 356.75, indicating notable volatility.\n\nIn terms of technical indicators, the weekly MACD and KST are bearish, while the monthly metrics show a mildly bullish trend. The daily moving averages suggest a mildly bullish sentiment, contrasting with the bearish signals from the weekly Bollinger Bands. The On-Balance Volume (OBV) indicates bullish momentum on a weekly basis, although it shows no trend on a monthly scale.\n\nWhen comparing the company's performance to the Sensex, Medicamen's stock return over the past week has been -11.66%, while the Sensex returned -2.16%. Over a one-mon..."
      },
      {
        "title": "Medicamen Biotech Reports Positive Turnaround Amid Long-Term Growth Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-downgraded-to-sell-amid-long-term-growth-challenges-and-profit-decline-1178318",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/MedicamenBiotec_mojoScore_563430.png",
        "date": "2025-03-03 18:40:14",
        "description": "Medicamen Biotech has recently experienced a change in evaluation following a positive financial performance in Q3 FY24-25, ending a streak of negative results. However, concerns linger regarding its long-term growth, with declining operating profit and a lack of domestic mutual fund investment, despite a conservative financial structure."
      }
    ],
    "total": 4189,
    "sid": "770569",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/medicamen-biotech-770569"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 (LODR) - Updates",
      "datetime": "08-Apr-2025",
      "details": "Announcement under Regulation 30 (LODR)- Updates",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 31(4) Of The Securities And Exchange Board Of India (Substantial Acquistion Of Shares And Takeovers) Regulation 2011 For The Financial Year Ended On March 31 2025",
      "datetime": "08-Apr-2025",
      "details": "Please find attached disclosure under Regulation 31(4) of SEBI (SAST) Regulation 2011",
      "source": "BSE"
    },
    {
      "caption": "Announcment Under Regulation 30 (LODR)- Update",
      "datetime": "03-Apr-2025",
      "details": "Announcement under Regulation 30 (LODR) - Update",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Medicamen Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 24",
          "dt": "2024-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Medicamen Biotech Shows Mixed Technical Trends Amid Strong Long-Term Performance

2025-04-01 08:02:34

Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 479.30, showing a notable increase from the previous close of 453.40. Over the past year, Medicamen has demonstrated a strong performance with a return of 25.11%, significantly outpacing the Sensex, which recorded a return of 5.11% in the same period. In terms of technical indicators, the weekly MACD and Bollinger Bands suggest a bearish sentiment, while the monthly MACD indicates a mildly bullish trend. The daily moving averages lean towards a mildly bearish outlook, reflecting mixed signals in the short term. The KST also shows a bearish trend on a weekly basis, contrasting with a mildly bullish monthly perspective. Despite recent fluctuations, Medicamen's long-term performance remains impressive, particularly...

Medicamen Biotech Faces Technical Trend Shifts Amid Market Volatility

2025-03-26 08:03:29

Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 451.00, down from a previous close of 477.35, with a 52-week high of 630.00 and a low of 377.00. Today's trading saw a high of 483.65 and a low of 451.00, indicating some volatility. The technical summary reveals a bearish sentiment in several indicators. The MACD shows a bearish trend on a weekly basis, while the monthly perspective is mildly bullish. Bollinger Bands and moving averages also reflect bearish conditions, suggesting a cautious outlook. The KST indicates a bearish trend weekly, with a mildly bullish stance monthly. Notably, the RSI shows no signals on both weekly and monthly charts, indicating a lack of momentum. In terms of performance, Medicamen Biotech's stock return over the past week stands at...

Medicamen Biotech's Technical Trends Indicate Mixed Outlook Amid Market Dynamics

2025-03-24 08:01:49

Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 485.30, showing a notable increase from the previous close of 474.65. Over the past year, Medicamen Biotech has demonstrated a return of 19.31%, significantly outperforming the Sensex, which recorded a return of 5.87% in the same period. The technical summary indicates a mixed outlook, with the MACD showing bearish signals on a weekly basis while being mildly bullish on a monthly scale. The Bollinger Bands reflect a mildly bearish trend weekly, and moving averages also suggest a mildly bearish stance. Notably, the KST presents a similar divergence, indicating bearish momentum weekly but a mildly bullish trend monthly. In terms of stock performance, Medicamen Biotech has experienced fluctuations, with a 52-week h...

Medicamen Biotech Faces Technical Trend Shift Amid Market Evaluation Revision

2025-03-18 08:02:47

Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 414.40, down from a previous close of 430.10, with a 52-week high of 630.00 and a low of 377.00. The technical summary indicates a bearish sentiment in various indicators, including the MACD and Bollinger Bands on both weekly and monthly charts. The moving averages also reflect a bearish trend, while the KST shows a mildly bullish stance on a monthly basis. The Relative Strength Index (RSI) currently shows no signal, suggesting a lack of momentum in either direction. In terms of performance, Medicamen Biotech's returns have varied significantly over different time frames. Over the past week, the stock has seen a decline of 5.84%, while the Sensex has remained relatively stable with a return of 0.07%. On a year-...

Medicamen Biotech Faces Stock Volatility Amidst Mixed Long-Term Performance Trends

2025-03-17 18:00:33

Medicamen Biotech Ltd, a microcap player in the Pharmaceuticals & Drugs industry, has experienced notable fluctuations in its stock performance. With a market capitalization of Rs 547.00 crore, the company currently holds a price-to-earnings (P/E) ratio of 62.65, significantly higher than the industry average of 35.59. Over the past year, Medicamen Biotech has shown a performance increase of 3.98%, outperforming the Sensex, which rose by 2.10%. However, recent trends indicate a decline, with the stock down 3.65% today, contrasting with the Sensex's gain of 0.46%. The stock has also faced challenges over the past week and month, with declines of 5.84% and 7.04%, respectively. Longer-term performance metrics reveal a more complex picture. Year-to-date, Medicamen Biotech is down 18.63%, while over three years, it has decreased by 38.06%. In contrast, the stock has shown significant growth over the past five ...

Medicamen Biotech Faces Mixed Technical Trends Amid Market Volatility and Declining Returns

2025-03-12 08:02:12

Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 413.10, down from a previous close of 440.10, with a notable 52-week high of 630.00 and a low of 356.75. Today's trading saw a high of 458.95 and a low of 410.25, indicating some volatility in its performance. The technical summary reveals a mixed outlook, with the MACD showing bearish signals on a weekly basis while maintaining a mildly bullish stance monthly. The Bollinger Bands and KST also reflect bearish trends on a weekly basis, suggesting caution in the short term. Meanwhile, moving averages indicate a mildly bullish trend daily, which contrasts with the overall bearish sentiment observed in other indicators. In terms of returns, Medicamen Biotech has faced challenges compared to the Sensex. Over the past...

Medicamen Biotech Experiences Technical Trend Adjustments Amid Mixed Market Signals

2025-03-11 08:03:24

Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs sector, has recently undergone a technical trend adjustment. The company's current stock price stands at 440.10, reflecting a notable decline from the previous close of 481.15. Over the past year, Medicamen has faced challenges, with a stock return of -6.76%, contrasting with a marginally positive return of -0.01% for the Sensex during the same period. The technical summary indicates mixed signals across various indicators. The MACD shows a bearish trend on a weekly basis while being mildly bullish monthly. The Bollinger Bands and KST also reflect bearish tendencies on a weekly scale, with the moving averages indicating a mildly bullish stance daily. Notably, the Relative Strength Index (RSI) shows no significant signals for both weekly and monthly evaluations. In terms of performance, Medicamen's stock has experienced a significant drop ...

Medicamen Biotech Faces Technical Trend Shifts Amid Market Volatility

2025-03-05 08:02:19

Medicamen Biotech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 478.95, slightly above its previous close of 477.50. Over the past year, Medicamen has experienced a 52-week high of 630.00 and a low of 356.75, indicating notable volatility. In terms of technical indicators, the weekly MACD and KST are bearish, while the monthly metrics show a mildly bullish trend. The daily moving averages suggest a mildly bullish sentiment, contrasting with the bearish signals from the weekly Bollinger Bands. The On-Balance Volume (OBV) indicates bullish momentum on a weekly basis, although it shows no trend on a monthly scale. When comparing the company's performance to the Sensex, Medicamen's stock return over the past week has been -11.66%, while the Sensex returned -2.16%. Over a one-mon...

Medicamen Biotech Reports Positive Turnaround Amid Long-Term Growth Concerns

2025-03-03 18:40:14

Medicamen Biotech has recently experienced a change in evaluation following a positive financial performance in Q3 FY24-25, ending a streak of negative results. However, concerns linger regarding its long-term growth, with declining operating profit and a lack of domestic mutual fund investment, despite a conservative financial structure.